July 28, 2015
Authored and Edited by Elizabeth D. Ferrill
Trading Technologies v. Open E Cry, No. 15-1547 - Courtroom 201
This case provides another opportunity for the Federal Circuit to expand its precedent applying the four-factor test for motions to stay pending CBM review. The district court denied a stay when, as Trading Technologies argues, only a subset of the 16 asserted patents were subject to CBM and many of the defendants had not agreed to be bound by the statutory estoppel that applies to the petitioner.
Prolitec v. ScentAir Technologies, No. 15-1020 - Courtroom 402
In another appeal involving motions to amend at the PTAB, Prolitec argues that the PTAB abused its discretion by denying its motion to amend. It also claims that the PTAB failed to analyze the substitute claim as a whole, and that its regulations governing amendments are arbitrary. ScentAir counters that the amendment was taught by the prior art. The PTAB has intervened in this case.
ClearCorrect Operating v. ITC, No. 14-1527; Align Technology v. ITC, No. 14-1533 - Courtroom 201
In a closely watched case, the Federal Circuit will determine whether digital data (used to create 3D models for Invisalign® braces) constitutes an “article” within the meaning of Section 337 or whether Section 337 only applies to physical items. The ITC found ClearCorrect liable for infringement by downloading the 3D models. So the Federal Circuit will also decide whether “importation” in Section 337 gives the ITC authority over the international transmission of digital files. Many amici have filed briefs in this case.
Copyright © 2015 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP.
DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. One of our lawyers will be happy to discuss the possibility of representation with you. Additional disclaimer information.
Webinar
Data and Market Exclusivity: An Update on China’s New Law and Comparisons to the US and Europe
November 19, 2026
Webinar
Conference
2nd Annual Forum on Pharma & Biotech Patent Litigation USA & Canada
October 14-16, 2026
New York
Articles
California Court Considers CIPA’s Application to Online Tracking as New Law Limits Private Actions
October 7, 2026
INCONTESTABLE® Blog
October 7, 2026
Federal Circuit IP Blog
Federal Circuit Affirms PTAB Obviousness Finding in DRAM Data Path Patent
October 5, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.